Please wait while the formulary information is being retrieved.
DANAZOL (DANAZOL)
- Endometriosis
- Prevention of angioedema attack in hereditary angioedema
- Fibrocystic breast disease
100 mg capsule
- 1 capsule (100 mg) by oral route 2 times per day
200 mg capsule
- 1 capsule (200 mg) by oral route 2 times per day
50 mg capsule
- 1 capsule (50 mg) by oral route 2 times per day
Endometriosis
- 1 capsule (100 mg) by oral route 2 times per day
- 2 capsules (100 mg) by oral route 2 times per day
- 2 capsules (200 mg) by oral route 2 times per day
Fibrocystic breast disease
- 1 capsule (50 mg) by oral route 2 times per day
- 1 capsule (100 mg) by oral route 2 times per day
- 2 capsules (100 mg) by oral route 2 times per day
- 2 capsules (200 mg) by oral route 2 times per day
Prevention of angioedema attack in hereditary angioedema
- 1 capsule (50 mg) by oral route 2 times per day
- 1 capsule (50 mg) by oral route 3 times per day
- 2 capsules (100 mg) by oral route 3 times per day
- 1 capsule (100 mg) by oral route 2 times per day
- 1 capsule (100 mg) by oral route 3 times per day
- 2 capsules (100 mg) by oral route 2 times per day
- 1 capsule (200 mg) by oral route 2 times per day
- 1 capsule (200 mg) by oral route 3 times per day
- 2 capsules (200 mg) by oral route 2 times per day
- 2 capsules (200 mg) by oral route 3 times per day
- ezetimibe-simvastatin
- niacin-simvastatin
- Simcor
- simvastatin
- Vytorin 10-10
- Vytorin 10-20
- Vytorin 10-40
- Vytorin 10-80
- Zocor
Contraindicated
- Coumadin
- cyclosporine
- cyclosporine modified
- Gengraf
- Jantoven
- Neoral
- Sandimmune
- warfarin
Severe
Moderate
- Advicor
- Altoprev
- Astagraf Xl
- carbamazepine
- Carbatrol
- Epitol
- Equetro
- Hecoria
- lovastatin
- Mevacor
- niacin-lovastatin
- Prograf
- tacrolimus
- Tegretol
- Tegretol Xr
- Angina
- Chronic heart failure
- Lactating mother
- Porphyria
- Pregnancy
Contraindicated
- Carcinoma of breast
- Disease of liver
- Kidney disease with reduction in GFR
- Mixed hyperlipidemia
- Thromboembolic disorder
Severe
Moderate
- Migraine
- Seizure disorder
DANAZOL (DANAZOL)
- Endometriosis
- Prevention of angioedema attack in hereditary angioedema
- Fibrocystic breast disease
- Abnormal vaginal bleeding
- Amenorrhea
- Breast size decreased
- Irregular menstrual periods
- Acne vulgaris
- Weight gain
More Frequent
Severe
Less Severe
- Edema
- Virilism
- Alopecia
- Flushing
- Hypoestrogenism
- Vaginal dryness
- Voice change
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute arterial thromboembolism
- Acute intermittent porphyria
- Acute pancreatitis
- Carpal tunnel syndrome
- Cataracts
- Cerebrovascular accident
- Disease of liver
- Disorder of lipid metabolism
- Eosinophilia
- Gingival bleeding
- Hematuria
- Idiopathic intracranial hypertension
- Jaundice
- Leukocytosis
- Neoplasm of liver
- Nipple discharge
- Peliosis hepatis
- Rhabdomyolysis
- Skin rash
- Splenic peliosis
- Stevens-johnson syndrome
- Thrombocytopenic disorder
- Thromboembolic disorder
- Urticaria
Less Severe
- Hyperhidrosis
- Mood changes
- Nervousness
- Oligospermia
- Pruritus of skin
- Skin photosensitivity
Contraindicated
None
Severe Precaution
Danazol
Safety and efficacy not established. risk of adverse androgenic effects.
- 1 Day – 13 Years
- Safety and efficacy not established. risk of adverse androgenic effects.
Management or Monitoring Precaution
None
Danazol
- Severity Level:
X
- Additional Notes:
Contraindicated
Danazol
Use not recommended. possibility of serious adverse effects exists.
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Use not recommended. possibility of serious adverse effects exists. |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Danazol
General-May cause fluid retention.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- This medication must not be used during pregnancy. It may harm an unborn baby. In women of childbearing age, this medication should be started during their menstrual period.<br /><br />If not, then they should have a negative pregnancy test before starting this medication. It is important to prevent pregnancy while using this medication. Consult your doctor for more details and to discuss the use reliable forms of non-hormonal birth control (such as condoms, diaphragm with spermicide) while using this medication.<br /><br />If you become pregnant or think you may be pregnant, tell your doctor right away. Danazol has rarely caused very serious (possibly fatal) blood clots (such as stroke), liver disease, and increased pressure on the brain (benign intracranial hypertension). Seek immediate medical attention if you have any symptoms of these side effects, including weakness on one side of the body, slurred speech, vision changes, severe stomach/abdominal pain, dark urine, persistent nausea/vomiting, yellowing eyes/skin, mental/mood changes (such as confusion), severe/persistent headache.
| Endometriosis | |
| N80 | Endometriosis |
| N80.0 | Endometriosis of uterus |
| N80.1 | Endometriosis of ovary |
| N80.2 | Endometriosis of fallopian tube |
| N80.3 | Endometriosis of pelvic peritoneum |
| N80.4 | Endometriosis of rectovaginal septum and vagina |
| N80.5 | Endometriosis of intestine |
| N80.6 | Endometriosis in cutaneous scar |
| N80.8 | Other endometriosis |
| N80.9 | Endometriosis, unspecified |
| Fibrocystic breast disease | |
| N60.1 | Diffuse cystic mastopathy |
| N60.11 | Diffuse cystic mastopathy of right breast |
| N60.12 | Diffuse cystic mastopathy of left breast |
| N60.19 | Diffuse cystic mastopathy of unspecified breast |
| N60.3 | Fibrosclerosis of breast |
| N60.31 | Fibrosclerosis of right breast |
| N60.32 | Fibrosclerosis of left breast |
| N60.39 | Fibrosclerosis of unspecified breast |
| Prevention of angioedema attack in hereditary angioedema | |
| D84.1 | Defects in the complement system |
| 0-9 | A-Z |
|---|---|
| D84.1 | Defects in the complement system |
| N60.1 | Diffuse cystic mastopathy |
| N60.11 | Diffuse cystic mastopathy of right breast |
| N60.12 | Diffuse cystic mastopathy of left breast |
| N60.19 | Diffuse cystic mastopathy of unspecified breast |
| N60.3 | Fibrosclerosis of breast |
| N60.31 | Fibrosclerosis of right breast |
| N60.32 | Fibrosclerosis of left breast |
| N60.39 | Fibrosclerosis of unspecified breast |
| N80 | Endometriosis |
| N80.0 | Endometriosis of uterus |
| N80.1 | Endometriosis of ovary |
| N80.2 | Endometriosis of fallopian tube |
| N80.3 | Endometriosis of pelvic peritoneum |
| N80.4 | Endometriosis of rectovaginal septum and vagina |
| N80.5 | Endometriosis of intestine |
| N80.6 | Endometriosis in cutaneous scar |
| N80.8 | Other endometriosis |
| N80.9 | Endometriosis, unspecified |
Formulary Reference Tool